Annual Scientific Meeting Agenda – Tuesday, October 2120. What Is the Optimum Time to Do Endoscopy in AcuteCaustic Ingestion?Munish Ashat, MD, Pradeep K. Siddappa, DM, Saroj K. Sinha,DM, Usha Dutta, DM, Rakesh Kochhar, DM, Gastroenterology,Post Graduate Institute of Medical Education and Research,Panchkula, Haryana, India21. Volumetric Laser Endomicroscopy in Barrett’s Esophagus– Feasibility of Use and Detection of Dysplasia in ClinicalPracticeJeffrey Mosko, MD, FRCPC, Sumeet K. Tewani, MD, IvanaDzeletovic, MD, Gyanprakash Ketwaroo, MD, Tyler Berzin, MD,Ram Chuttani, MD, Mandeep Sawhney, MD, Douglas Pleskow,MD, Beth Israel Deaconess Medical Center and Harvard MedicalSchool, Boston, MA22. Natural Orifice Endoscopic Surgery (NOTES) Techniquesfor Full Thickness R0 Endoscopic Resection of Deep SeatedSubepithelial Tumors (SETs): First U.S. CasesStavros Stavropoulos, MD, Rani J. Modayil, MD, Collin Brathwaite,MD, Kumkum S. Patel, MD, Thomas Coppola, DO, JohnAllendorf, MD, David Friedel, MD, James Grendell, MD, WinthropUniversity Hospital, Mineola, NY23. Over-The-Scope-Clip and Cap-Assisted Method for theResection of Submucosal Lesions of the Gastrointestinal Tract:A Multi-Center StudyShabnam Sarker, MD, Marcel Sandmann, MD, Martin Faendrich,MD, Kondal Kyanam Kabir Baig, MD, Klaus Monkemuller, MD,PhD, Gastroenterology, University of Alabama, Birmingham, AL,Klinikum Dortmund, Dortmund, Germany24. Is Cold Biopsy the Best Method for Diminutive ColonicPolyp Removal? A Systematic Review and Meta-analysisDany Raad, MD, Priyam Tripathi, MD, MPH, Gregory Cooper, MD,FACG, Yngve Falck-Ytter, MD, Case Western Reserve University/University Hospitals Case Medical Center/VA Medical Center,Cleveland, OH25. Withdrawal Times, Adenoma Detection Rates, and Risk ofInterval Colorectal Cancer2014 ACG Colorectal Cancer Prevention AwardAasma Shaukat, MD, MPH, FACG, Thomas Rector, PhD, TimothyR. Church, PhD, Frank Lederle, MD, Adam S. Kim, MD, JeffreyRank, MD, John I. Allen, MD, Minneapolis VA Medical Center,Minneapolis, MN, University of Minnesota, Minneapolis, MN, MinnesotaGastroenterology, PA, Minneapolis, MN26. A Phase-3 Placebo-Controlled Trial of Celecoxib inPediatric Subjects With Familial Adenomatous PolyposisCarol A. Burke, MD, FACG, Patrick M. Lynch, MD, Robin K. Phillips,MD, Manuela F. Berger, MD, Chunming Li, PhD, Dinu Iorga,MD, Cleveland Clinic, Cleveland, OH, MD Anderson Cancer Center,Houston, TX, St. Marks Hospital, Middlesex, London, UnitedKingdom, Pfizer, Inc., New York, NYcombined abstracts27A. Statewide, Population-Based Lynch Syndrome (LS)Screening by Microsatellite Instability (MSI) in ColorectalCancer (CRC) Patients Aged ≤50 Years: Frequency,Determinants of Testing, and Result Analysis2014 ACG Governors Award for Excellence in Clinical ResearchJordan J. Karlitz, MD, Mei-chin Hsieh, MSPH, Yong Liu, BS,Christine Blanton, MD, Beth Schmidt, MSPH, Xiao-Cheng Wu,MD, MPH, Vivien W. Chen, PhD, MPH, Medicine, Tulane UniversitySchool of Medicine, New Orleans, LA; Louisiana Tumor Registry,School of Public Health, Louisiana State University HealthSciences Center, New Orleans, LA27B. Population-Based Lynch Syndrome (LS) Screening inColorectal Cancer (CRC) Patients Aged ≤50 Years: A StatewideAnalysis of Timing of Microsatellite Instability (MSI) TestResult Availability in Relation to Surgery2014 ACG Governors Award for Excellence in Clinical ResearchJordan J. Karlitz, MD, Mei-chin Hsieh, MSPH, Yong Liu, BS,Christine Blanton, MD, Beth Schmidt, MD, Meredith Sherrill, MD,Sanjay Sikka, MD, Giuseppe Gagliardi, MD, Xiao-Cheng Wu, MD,MPH, Vivien W. Chen, PhD, MD, Medicine, Tulane UniversitySchool of Medicine, New Orleans, LA, Louisiana Tumor Registry,School of Public Health, Louisiana State University HealthSciences Center, New Orleans, LAPlenary Session 2: LiverMODERATORS: Kris V. Kowdley, MD, FACGPaul Y. Kwo, MD, FACG28. Association Between Aspirin Use and Prevalence of NonalcoholicFatty Liver Disease: A Cross-Sectional Study Fromthe Third National Health and Nutrition Examination SurveyHuafeng Shen, MD, Ghulamullah Shahzad, MD, MahreemaJawairia, MD, Paul Mustacchia, MD, NUMC, East Meadow, NY29. Serum Ceruloplasmin, Ferritin, and Their Ratio AreSignificantly Associated with Nonalcoholic Steatohepatitis inPatients with NAFLDDanny Issa, MD, Rocio Lopez, MS, Ariel E. Feldstein, MD,Mohamed Yaseen Alsabbagh, MD, Naim Alkhouri, MD, ClevelandClinic, Cleveland, OH30. Mean Platelet Volume, Red Cell Distribution Width toPlatelet Count Index, Globulin Platelet Index and 12 OtherSimple Non-invasive Fibrosis Scores: How Much Do RoutineBlood Tests Tell About Liver Fibrosis?2014 ACG Governors Award for Excellence in Clinical ResearchRagesh B. Thandassery, MD, DM, Anil John, MD, DM, MRCP,Madiha Soofi, MD, Syed A. Mohiuddin, MBBS, Mohammed E.Elbadri, MD, Saad Al Kaabi, MD, Division of Gastroenterology,Department of Medicine, Hamad Medical Corporation, Doha,Qatar, Department of Laboratory Medicine and Pathology, HamadMedical Corporation, Doha, Qatar31. Idiosyncratic Drug-Induced Liver Injury (DILI) in the UnitedStates: A Report of 1,257 Prospectively Enrolled Patients2014 ACG Governors Award for Excellence in Clinical ResearchNaga P. Chalasani, MD, FACG, Herbert Bonkovsky, MD, FACG,Robert Fontana, MD, William Lee, MD, FACG, Andrew Stolz, MD,Jay Talwalkar, MD, FACG, Rajender Reddy, MD, FACG, Paul Watkins,MD, Victor Navarro, MD, Huiman Barnhart, PhD, JiezhunGu, PhD, Jose Serrano, MD, Indiana University School of Medicine,Indianapolis, IN, Carolinas Health Care System, Charlotte,NC, University of Michigan, Ann Arbor, MI, UT-Southwestern, Dallas,TX, University of Southern California, Los Angeles, CA, MayoClinic, Rochester, MN, University of Pennsylvania, Philadelphia,PA, University of North Carolina, Chapel Hill, NC, Einstein MedicalCenter, Philadelphia, PA, Duke Clinical Research Institute,Durham, NC, NIDDK, Bethesda, MDFor more information on ACG 2014 and to register, visit www.acgmeetings.gi.org.30
Annual Scientific Meeting Agenda – Tuesday, October 2132. Health Related Quality of Life (HRQL) and Health Utilities(HU) of Patients With Chronic Hepatitis C (CH-C) Treated Withan Interferon (IFN)-Free Regimen Containing Ledipasvir (LDV)and Sofosbuvir (SOF)Zobair Younossi, MD, MPH, FACG, Maria Stepanova, PhD, PatrickMarcellin, MD, PhD, Nezam Afdhal, MD, Kris V. Kowdley, MD,FACG, Stefan Zeuzem, MD, Linda Henry, PhD, Sharon Hunt,MBA, Center for Liver Diseases, Department of Medicine, InovaFairfax Hospital, Falls Church, VA; CLDQ LLC, Washington, DC,Viral Hepatitis Research Unit in Hospital Beaujon, Clichy, France,Beth Israel Deaconess Medical Center, Boston, MA, DigestiveDiseases Institute, Digestive Diseases Institute, Virginia MasonClinic, Seattle, WA, Department of Medicine, J.W. Goethe UniversityHospital, Frankfurt, Germany, Betty and Guy Beatty Centerfor Integrated Research, Inova Health System, Falls Church, VA33. Management of Hemoglobin Decrease in Patients TreatedWith ABT-450/Ritonavir/Ombitasvir and Dasabuvir With orWithout Ribavirin in HCV Genotype 1-infected PatientsVinod Rustgi, MD, FACG, David Bernstein, MD, FACG, ThomasSepe, MD, FACG, William King, MD, Moises Diago, MD, PietroAndreone, MD, Daniel Forton, PhD, Hendrik Reesink, MD, PeterFerenci, MD, Yiran Hu, MS, Jeffrey Enejosa, MD, Daniel Cohen,MD, Yan Luo, MD, PhD, Marcos Pedrosa, MD, PhD, JohnVierling, MD, Metropolitan Research, Fairfax, VA, North ShoreUniversity Hospital (BRANY), Manhasset, NY, University Gastroenterology,Providence, RI, Trial Management Associates, LLC,Wilmington, NC, Hospital Quirón de Valencia, Unidad de Hepatología,Servicio de Aparato Digestivo, Valencia, Spain, Departmentof Medical and Surgical Sciences, University of Bologna,Bologna, Italy, St. George’s, University of London, London, UnitedKingdom, Academisch Medisch Centrum, Universiteit van Amsterdam,Gastroenterology & Hepatology, Amsterdam, Netherlands,Department of Internal Medicine 3, Medical University of Vienna,Vienna, Austria, AbbVie Inc., North Chicago, IL, Advanced LiverTherapies, Baylor St. Luke’s Medical Center, Houston, TX34. Sex, Age and Race Are Associated With Increased Risk ofExposure to Hepatitis E in the U.S.Tyler B. Fleming, MD, Alla Y. Grigorian, MD, PhD, Bilal Aslam,MS, IV, Philip Westgate, PhD, Houssam E. Mardini, MD, MPH,University of Kentucky College of Medicine, Lexington, KY, Universityof Kentucky College of Public Health, Lexington, KY35. The Impact of Hyponatremia on the Outcomes ofWait-Listed and Transplanted Patients With Liver CirrhosisMohammed Eyad Yaseen Alsabbagh, MD, Bayan Alsuleiman, MD,Naim Alkhouri, MD, Cleveland Clinic, Cleveland, OH36. Reserved for Late Breaking Abstract10:00 am – 10:30 am J. Edward Berk DistinguishedLecture (Terrace Ballroom 3)GI and Endoscopic Training for theFuture GastroenterologistRichard A. Kozarek, MD, FACGIdentify the fundamentals of GI andendoscopic training for tomorrow’s GI.Introduced by:Harry E. Sarles, Jr., MD, FACGACG PresidentSee page 4 for more information.10:00 am – 4:30 pm Exhibit Hall Opens(Exhibit Halls DE)10:00 am – 4:30 pm Hands-on Workshop Center(Exhibit Halls DE)10:30 am – 11:30 am Break – Visit Exhibits(Exhibit Halls DE)10:30 am – 11:30 am Exhibitor theater(Exhibit Halls DE)11:30 am – 12:45 pm Simultaneous Symposia 3simultaneous symposia 3a: Quality in Colonoscopy:Here and Nowmoderator: Douglas K. Rex, MD, MACGQuality Indicators in Colonoscopy and How to Improve Them inPracticeAasma Shaukat, MD, MPH, FACGDefine current quality indicators and discuss technology and techniquesto improve them in practice.Detection and Resection of Serrated PolypsDouglas K. Rex, MD, MACGDetermine the classification, pathology variation and methods to improvedetection and resection of serrated polyps.Controversies in Surveillance GuidelinesDennis J. Ahnen, MDAnalyze surveillance guidelines for serrated polyps and other grey areas.simultaneous symposia 3b: Reading Between the Lines:The Refractory Esophageal Patient – What theGuidelines Do Not Addressmoderator: Evan S. Dellon, MD, MPHAchalasia: New Treatment ParadigmsSteven R. DeMeester, MD, FACGDescribe new treatments, including POEM, as well as patient selection forsurgical therapy and management of post-surgical complications.EoE: When Steroids FailEvan S. Dellon, MD, MPHDiscuss the reasons and treatment approaches for steroid-refractory EoEpatients, including dietary elimination and dilation.Refractory GERD: What Are the Options in 2014?Ronnie Fass, MD, FACGDescribe current treatment options for PPI-refractory GERD, optimalselection of patients for surgery and post-op complications/recurrences.12:45 pm – 2:15 pm Lunch Break(Exhibit Halls DE)12:45 pm – 2:15 pm Poster Session(Exhibit Halls DE)12:45 pm – 1:15 pm Exhibitor theater(Exhibit Halls DE)1:45 pm – 2:15 pm Exhibitor theater(Exhibit Halls DE)ANNUALMEETING31For more information on ACG 2014 and to register, visit www.acgmeetings.gi.org.
- Page 6 and 7: Featured LecturesDavid Sun LectureT
- Page 8: Special EventsThere are numerous op
- Page 12 and 13: ACG's 2014 Optional Friday Coursesa
- Page 15 and 16: asge-sponsored endoscopy courseACG'
- Page 18: Optional Friday Courses / ACG's 201
- Page 21 and 22: ACG's 2014 Postgraduate Course - Sa
- Page 23 and 24: ACG's 2014 Postgraduate Course - Su
- Page 25 and 26: ACG's 2014 Annual Scientific Meetin
- Page 27 and 28: Annual Scientific Meeting Agenda -
- Page 29 and 30: Annual Scientific Meeting Agenda -
- Page 31: Annual Scientific Meeting Agenda -
- Page 35 and 36: Annual Scientific Meeting Agenda -
- Page 37 and 38: Annual Scientific Meeting Agenda -
- Page 39 and 40: Annual Scientific Meeting - Faculty
- Page 41 and 42: Poster PresentationsSunday, October
- Page 43 and 44: Poster Presentations - Sunday, Octo
- Page 45 and 46: Poster Presentations - Sunday, Octo
- Page 47 and 48: Poster Presentations - Sunday, Octo
- Page 49 and 50: Poster Presentations - Sunday, Octo
- Page 51 and 52: Poster Presentations - Sunday, Octo
- Page 53 and 54: Poster Presentations - Sunday, Octo
- Page 55 and 56: Poster Presentations - Sunday, Octo
- Page 57 and 58: Poster Presentations - Sunday, Octo
- Page 59 and 60: Poster Presentations - Sunday, Octo
- Page 61 and 62: Poster Presentations - Sunday, Octo
- Page 63 and 64: Poster Presentations - Sunday, Octo
- Page 65 and 66: Poster Presentations - Sunday, Octo
- Page 67 and 68: Poster Presentations - Sunday, Octo
- Page 69 and 70: Poster Presentations - Monday, Octo
- Page 71 and 72: Poster Presentations - Monday, Octo
- Page 73 and 74: Poster Presentations - Monday, Octo
- Page 75 and 76: Poster Presentations - Monday, Octo
- Page 77 and 78: Poster Presentations - Monday, Octo
- Page 79 and 80: Poster Presentations - Monday, Octo
- Page 81 and 82: Poster Presentations - Monday, Octo
- Page 83 and 84:
Poster Presentations - Monday, Octo
- Page 85 and 86:
Poster Presentations - Monday, Octo
- Page 87 and 88:
Poster Presentations - Monday, Octo
- Page 89 and 90:
Poster Presentations - Monday, Octo
- Page 91 and 92:
Poster Presentations - Monday, Octo
- Page 93 and 94:
Poster Presentations - Monday, Octo
- Page 95 and 96:
Poster Presentations - Tuesday, Oct
- Page 97 and 98:
Poster Presentations - Tuesday, Oct
- Page 99 and 100:
Poster Presentations - Tuesday, Oct
- Page 101 and 102:
Poster Presentations - Tuesday, Oct
- Page 103 and 104:
Poster Presentations - Tuesday, Oct
- Page 105 and 106:
Poster Presentations - Tuesday, Oct
- Page 107 and 108:
Poster Presentations - Tuesday, Oct
- Page 109 and 110:
Poster Presentations - Tuesday, Oct
- Page 111 and 112:
Poster Presentations - Tuesday, Oct
- Page 113 and 114:
Poster Presentations - Tuesday, Oct
- Page 115 and 116:
Poster Presentations - Tuesday, Oct
- Page 117 and 118:
Poster Presentations - Tuesday, Oct
- Page 119 and 120:
Poster Presentations - Tuesday, Oct
- Page 121 and 122:
Poster Presentations - Tuesday, Oct
- Page 123 and 124:
General InformationAccreditationThe
- Page 125 and 126:
ACG Auxiliary Events and ToursAuxil
- Page 127 and 128:
ACG 2014 Registration FormMail to:
- Page 129 and 130:
Exhibit HallThe science and technol
- Page 131 and 132:
Child Care Registration FormThe Ame
- Page 133:
For ACG 2014 Annual Postgraduate Co